Cargando…

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer

Background: Ovarian cancer (OC) is the most lethal gynaecological cancer. It is often diagnosed at an advanced stage with poor chances for successful treatment. An accurate blood test for the early detection of OC could reduce the mortality of this disease. Methods: Autoantibody reactivity to 20 epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilyugin, Maxim, Ratajska, Magdalena, Stukan, Maciej, Concin, Nicole, Zeillinger, Robert, Irminger-Finger, Irmgard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305152/ https://www.ncbi.nlm.nih.gov/pubmed/34201956 http://dx.doi.org/10.3390/genes12070969

Ejemplares similares

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)

BARD1 serum autoantibodies for the detection of lung cancer
por: Pilyugin, Maxim, et al.
Publicado: (2017)

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
por: Klonowska, Katarzyna, et al.
Publicado: (2015)

Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012)

HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
por: Lepore, Ilaria, et al.
Publicado: (2013)

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome
por: Zhang, Y-Q, et al.
Publicado: (2012)

In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial Cells
por: Irminger-Finger, Irmgard, et al.
Publicado: (1998)

BARD1 mediates TGF-β signaling in pulmonary fibrosis
por: André, Pierre-Alain, et al.
Publicado: (2015)

Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer
por: Ratajska, Magdalena, et al.
Publicado: (2017)

Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021)

HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours
por: Brożek, Izabela, et al.
Publicado: (2006)

Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects
por: Wiczling, Paweł, et al.
Publicado: (2019)

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
por: Koczkowska, Magdalena, et al.
Publicado: (2018)

Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
por: Ratajska, Magdalena, et al.
Publicado: (2014)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

BARDES coming of age?
Publicado: (2022)

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
por: Weber-Lassalle, Nana, et al.
Publicado: (2019)

Dualistic Role of BARD1 in Cancer
por: Cimmino, Flora, et al.
Publicado: (2017)

BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1
por: Witus, Samuel R., et al.
Publicado: (2021)

Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
por: Suszynska, Malwina, et al.
Publicado: (2020)

RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
por: Zhu, Qian, et al.
Publicado: (2021)

Acting Shakespeare is outrageous!: playing the bard for beginners
por: Parker, Herb
Publicado: (2017)

A tribute to the Bards of BEACH : Experiment Summary
por: Gibson, V
Publicado: (2014)

Largest ever BARDES meeting held in Liverpool
Publicado: (2022)

BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation
por: Suszynska, Malwina, et al.
Publicado: (2019)

Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
por: Alenezi, Wejdan M., et al.
Publicado: (2020)

Lung and Intercostal Upper Abdomen Ultrasonography for Staging Patients with Ovarian Cancer: A Method Description and Feasibility Study
por: Stukan, Maciej, et al.
Publicado: (2020)

Accuracy of Pretreatment Ultrasonography Assessment of Intra-Abdominal Spread in Epithelial Ovarian Cancer: A Prospective Study
por: Tomasińska, Agnieszka, et al.
Publicado: (2021)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

D\barD and B\barB mixing
por: Checchia, P
Publicado: (1995)

Functional analysis of clinical BARD1 germline variants
por: Toh, Ming Ren, et al.
Publicado: (2019)

BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility
por: Fu, Wen, et al.
Publicado: (2017)

BRCA1-BARD1: the importance of being in shape
por: Daza-Martin, Manuel, et al.
Publicado: (2019)

A synergetic effect of BARD1 mutations on tumorigenesis
por: Li, Wenjing, et al.
Publicado: (2021)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma
por: Ryser, Stephan, et al.
Publicado: (2011)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_feo94tcbci21geledtrjf37qn1